Misplaced Pages:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox

This is an old revision of this page, as edited by Beetstra (talk | contribs) at 12:38, 6 December 2011 (Saving copy of the {{drugbox}} taken from revid 456582545 of page Reboxetine for the Chem/Drugbox validation project (updated: 'ChEMBL').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 12:38, 6 December 2011 by Beetstra (talk | contribs) (Saving copy of the {{drugbox}} taken from revid 456582545 of page Reboxetine for the Chem/Drugbox validation project (updated: 'ChEMBL').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

This page contains a copy of the infobox ({{drugbox}}) taken from revid 456582545 of page Reboxetine with values updated to verified values.

Reboxetine
Clinical data

Routes of administration	Oral
ATC code	N06AX18 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	94.5%
Protein binding	98%
Metabolism	Hepatic, CYP3A4-mediated
Elimination half-life	13 hours
Excretion	Renal
Identifiers
IUPAC name (R,R)-2-morpholine
CAS Number	98769-81-4
PubChem CID	127151
DrugBank	DB00234
ChemSpider	112870
UNII	947S0YZ36I
KEGG	D08472
Chemical and physical data
Formula	C₁₉H₂₃NO₃
Molar mass	313.391 g/mol g·mol
3D model (JSmol)	Interactive image
SMILES O(c1ccccc1OCC)(c2ccccc2)3OCCNC3
InChI InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3/t18-,19-/m1/s1 Key:CBQGYUDMJHNJBX-RTBURBONSA-N
(what is this?) (verify)

Fleishaker JC (2000). "Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression". Clinical Pharmacokinetics. 39 (6): 413–27. doi:10.2165/00003088-200039060-00003. PMID 11192474.
Edwards DM, Pellizzoni C, Breuel HP, Berardi A, Castelli MG, Frigerio E, Poggesi I, Rocchetti M, Dubini A, Strolin Benedetti M (1995). "Pharmacokinetics of reboxetine in healthy volunteers. Single oral doses, linearity and plasma protein binding". Biopharmaceutics & Drug Disposition. 16 (6): 443–60. doi:10.1002/bdd.2510160603. PMID 7579027.{{cite journal}}: CS1 maint: multiple names: authors list (link)